Discussion: Managing risk when using idelalisib

Steven E. Coutre, Jan A. Burger, John M. Pagel

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	13
Number of pages	1
Journal	Clinical Advances in Hematology and Oncology
Volume	14
Issue number	5
State	Published - 2016

ASJC Scopus subject areas

@article{4dcc546863b645859c8d854ec9ec2ace,

title = "Discussion: Managing risk when using idelalisib",

author = "Coutre, {Steven E.} and Burger, {Jan A.} and Pagel, {John M.}",

year = "2016",

language = "English (US)",

volume = "14",

pages = "13",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "5",

}

TY - JOUR

T1 - Discussion

T2 - Managing risk when using idelalisib

AU - Coutre, Steven E.

AU - Burger, Jan A.

AU - Pagel, John M.

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=85010424159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010424159&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 27168205

AN - SCOPUS:85010424159

SN - 1543-0790

VL - 14

SP - 13

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 5

ER -